Deep Learning using Susceptibility-Weighted MR Sequence to Detect Microbleeds and Classify Cerebral Small Vessel Disease

BackgroundMicrobleeds (CMBs) serve as neuroimaging biomarkers to assess risk of intracerebral hemorrhage and diagnose cerebral small vessel disease (CSVD). Therefore, detecting CMBs can evaluate the risk of intracerebral hemorrhage and use its presence to support CSVD classification, both are conducive to optimizing CSVD management. This study aimed to develop and test a deep learning (DL) model based on susceptibility-weighted MR sequence (SWS) to detect CMBs and classify CSVD to assist neurologists in optimizing CSVD management. MethodsPatients with arteriolosclerosis (aSVD), cerebral amyloid angiopathy (CAA), and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) treated at three centers were enrolled between January 2017 and May 2022 in this retrospective study. The SWSs of patients from two centers were used as the development set, and the SWSs of patients from the remaining center were used as the external test set. The DL model contains a Mask R-CNN for detecting CMBs and a multi-instance learning (MIL) network for classifying CSVD. The metrics for model performance included intersection over union (IoU), Dice score, recall, confusion matrices, receiver operating characteristic curve (ROC) analysis, accuracy, precision, and F1-score. ResultsA total of 364 SWS were recruited, including 336 in the development set and 28 in the external test set. IoU for the model was 0.523 {+/-} 0.319, Dice score 0.627 {+/-} 0.296, and recall 0.706 {+/-} 0.365 for CMBs detection in the external test set. For CSVD classification, the model achieved a weighted-average AUC of 0.908 (95% CI: 0.895-0.921), accuracy of 0.819 (95% CI: 0.768-0.870), weighted-average precision of 0.864 (95% CI: 0.831-0.897), and weighted-average F1-score of 0.829 (95% CI: 0.782-0.876) in the external set, outperforming the performance of the neurologist group. ConclusionThe DL model based on SWS can detect CMBs and classify CSVD, thereby assisting neurologists in optimizing CSVD management.